Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS: Health Spending Growth Slowed In ’10, But Will Be Nearly 20% Of GDP By 2020

This article was originally published in The Gray Sheet

Executive Summary

U.S. health care spending growth remained at historic lows in 2010, but CMS actuaries expect spending to pick up in the next several years as the economy recovers. By 2020, health care spending will take on a 19.8% share of the nation’s gross domestic product, up from 17.6% last year, according to a July 28 analysis.

You may also be interested in...



Health Care Spending Rate Slows To Record Low – CMS

The sluggish economy in 2009 slowed the growth of U.S. health care spending that year to 4%, the lowest growth rate seen in the 50 years during which the data has been tracked, according to a Jan. 5 report from the CMS Office of the Actuary.

Pricey Technology Is Key Driver Of Health Costs – Congressional Budget Offc.

Unsustainable growth in federal health care spending needs to be quelled by curbing inappropriate use of medical technologies, according to the Congressional Budget Office

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel